UNLOCK 2026: AI’s Impact on Drug Discovery

The UNLOCK 2026 summit convened world leaders in San Francisco on April 22, 2026 ^[1][2]. The one-day event focused on how artificial intelligence (AI) is transforming drug discovery and the life sciences ^[1][3]. Participants included Nobel Laureate David Baker and representatives from major firms like Genentech and AstraZeneca ^[1].

Speakers aimed to differentiate genuine advancements in biological research from marketing hype ^[3]. The summit highlighted new methods for accelerating scientific breakthroughs using modern AI models ^[1][2]. Attendees explored the practical integration of these tools within existing laboratory workflows ^[3].

Industry experts discussed how these technologies are applied to complex biological problems ^[1]. The gathering served as a platform for collaboration between researchers and technology companies ^[3]. Organizers emphasized that AI is now a central component of research in the life sciences sector ^[1].